Amoy Diagnostics Co., Ltd.
SZSE:300685
¥ 20.00
¥0.00 (0.00%)
¥ 20.00
¥0.00 (0.00%)
End-of-day quote: 05/18/2024

Amoy Diagnostics financials at a glance

The revenue of Amoy Diagnostics is reported as 1.04358 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0.6 Yuan Renminbi per share in 2023, which was 50 higher than 2022. And about 0.25385 billion Yuan Renminbi are reported as free cash flow in the financials of Amoy Diagnostics 2023. Dividends of 0.15 Yuan Renminbi per share were paid to shareholders of Amoy Diagnostics stock SZSE:300685 in fiscal 2023.

¥1.04B
Revenue
¥0.60
Earnings Per Share
83.05%
Gross Margin %
¥122.50M
Free Cash Flow
Revenue
1,043.58
Earnings Per Share
0.60
Gross Margin %
83.05
Free Cash Flow
122.50

Financials

Year Year TTM 2023 2022 2021 2020
Rev. Revenue N/A ¥1.04B ¥842.18M ¥917.03M ¥728.39M
GM % Gross Margin % 82.22% 83.05% 81.78% 83.95% 86.97%
OM Operating Margin 18.39% 25.82% 17.06% 25.63% 24.16%
EPS Earnings Per Share ¥0.55 ¥0.60 ¥0.40 ¥0.54 ¥0.37
Div. Dividends N/A ¥0.15 ¥0.14 ¥0.13 ¥0.14
PR % Payout Ratio % 0 25.00% 35.00% 24.07% 37.84%
Sha. Shares N/AM 400.21M 398.16M 399.1M 399.25M
OCF Operating Cash Flow N/A ¥298.72M ¥149.04M ¥168.16M ¥220.69M
FCF Free Cash Flow N/A ¥122.50M ¥70.75M ¥96.91M ¥162.91M
FCFS Free Cash Flow Per Share ¥0.57 ¥0.64 ¥0.18 ¥0.23 ¥0.74